Current Pharmaceutical Design
Title: Editorial [Hot Topic: Advances in the Pharmacological Approach to Sleep Disorders Executive (Guest Editor: Michelle Cao)]
Volume: 17 Issue: 15
Author(s): Michelle Cao
Affiliation:
Export Options
About this article
Cite this article as:
Cao Michelle, Editorial [Hot Topic: Advances in the Pharmacological Approach to Sleep Disorders Executive (Guest Editor: Michelle Cao)], Current Pharmaceutical Design 2011; 17 (15) . https://dx.doi.org/10.2174/138161211796197061
DOI https://dx.doi.org/10.2174/138161211796197061 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease
Current Neuropharmacology Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
Current Alzheimer Research Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's Disease, Depression, Schizophrenia and Ionizing Radiation Exposure
Current Medicinal Chemistry The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease
Current Alzheimer Research Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile
Current Drug Safety Adiposity and the Gut - The Role of Gut Hormones
Current Nutrition & Food Science “Early” or Timely Discharge in Kangaroo Mother Care: Evidence and Experience
Current Women`s Health Reviews Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder
Current Drug Safety New Drugs for Immune Targeting
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Energy Metabolism Impairment in Migraine
Current Medicinal Chemistry The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
CNS & Neurological Disorders - Drug Targets Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations
CNS & Neurological Disorders - Drug Targets Commentary: Research Highlights (Neuronal Nicotinic Acetylcholine Receptors: Emerging Therapeutic Targets for Alcoholism)
CNS & Neurological Disorders - Drug Targets CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Current Pharmaceutical Design Could Hippocampal Neurogenesis be a Future Drug Target for Treating Temporal Lobe Epilepsy?
CNS & Neurological Disorders - Drug Targets Mitochondrial Deficits Accompany Cognitive Decline Following Single Bilateral Intracerebroventricular Streptozotocin
Current Alzheimer Research Thyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Behavioral Intervention Technologies and Psychotherapy with Youth: A Review of the Literature
Current Psychiatry Reviews